- Report
- May 2025
- 185 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- July 2024
- 134 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- June 2025
- 72 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 90 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- May 2023
- 145 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- May 2024
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- April 2024
- 181 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- April 2024
- 132 Pages
Global
From €851EUR$950USD£725GBP
- Report
- June 2023
- 71 Pages
France
From €1477EUR$1,649USD£1,259GBP
€2109EUR$2,355USD£1,798GBP
- Report
- June 2023
- 88 Pages
China
From €1364EUR$1,523USD£1,162GBP
€1948EUR$2,175USD£1,661GBP
- Report
- June 2023
- 84 Pages
Germany
From €1477EUR$1,649USD£1,259GBP
€2109EUR$2,355USD£1,798GBP
- Report
- June 2023
- 73 Pages
South Korea
From €1364EUR$1,523USD£1,162GBP
€1948EUR$2,175USD£1,661GBP
- Report
- June 2023
- 80 Pages
Saudi Arabia
From €1364EUR$1,523USD£1,162GBP
€1948EUR$2,175USD£1,661GBP
- Report
- June 2023
- 79 Pages
Italy
From €1477EUR$1,649USD£1,259GBP
€2109EUR$2,355USD£1,798GBP

Point of Care Glucose Testing (POCT) is a type of glucose testing that is performed outside of a laboratory setting. It is typically used to monitor glucose levels in patients with diabetes, and is often used in emergency situations. POCT is a convenient and cost-effective way to measure glucose levels, as it does not require a laboratory or specialized equipment. The results are usually available within minutes, allowing for quick and accurate diagnosis and treatment. POCT is also used to monitor glucose levels in pregnant women, as well as to diagnose and monitor other conditions such as hypoglycemia.
The POCT market is growing rapidly, driven by the increasing prevalence of diabetes and other chronic conditions, as well as the need for rapid and accurate diagnosis and treatment. The market is also being driven by technological advancements, such as the development of portable and user-friendly devices.
Some companies in the POCT market include Abbott, Roche, Siemens, and LifeScan. Show Less Read more